Please login to the form below

Not currently logged in
Email:
Password:

Oragenics

This page shows the latest Oragenics news and features for those working in and with pharma, biotech and healthcare.

Meeting with resistance

Oragenics believes that large-scale, cost-effective production of clinical grade MU1140-S will be possible by use of DPOLTTM. ... It appears unlikely that NAI-107 is as far advanced in development as Oragenics' MU1140-S.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Dr Alan Joslyn becomes president and CEO of Oragenics Dr Alan Joslyn becomes president and CEO of Oragenics

    Dr Alan Joslyn becomes president and CEO of Oragenics. He will also serve on the company’ s board of directors. ... Florida-based Oragenics has appointed Dr Alan Joslyn as its new president, chief executive officer and member of the board of directors.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics